HPLC-MS/MS Analysis Of Carnitine And Acylcarnitines In Clinical Samples | 6030
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

HPLC-MS/MS Analysis of Carnitine and Acylcarnitines in Clinical Samples

2nd International Conference on Analytical & Bioanalytical Techniques

Charles L. Hoppel

ScientificTracks Abstracts: J Anal Bioanal Techniques

DOI: 10.4172/2155-9872.S1.02

Introduction: Detailed analysis of carnitine and acylcarnitines is used for: 1) Follow-up to positive tandem MS / newborn screening (TMS/NBS) results to eliminate false positives and resolve isomeric acylcarnitines, 2) Monitoring with accurate values (as opposed to a semi/pseudo quantitative screen), and 3) In support of clinical research, with accurate and precise values, isotopomer analysis, and isomer separation. Objective: Develop HPLC-MS/MS methods for the quantifi cation of acylcarnitines regardless of sample type, acyl chain length, or isomeric confi guration. Methods: 1) Isolation of acylcarnitines, 2) Sample simplifi cation, 3) Derivatization without inadvertent hydrolysis of acylcarnitines, 4) Chromatography that resolves isomeric acylcarnitines, 5) MRM detection, 6) Quantifi cation using standard compounds and class appropriate internal standards with multiple-point calibration curves, and 7) Validation, demonstrating accuracy, precision, and robust performance. Results: Accuracy - acetylcarnitine add-back experiments to plasma, urine, and skeletal muscle with values � 5% of expected values. Precision -acetylcarnitine batch-to-batch percent relative standard deviations less than 5% (N=18). Robustness - quality control values over a 5 month period had a percent relative standard deviation of � 6%, with no individual value in excess of �15% of the expected value. Reference intervals were determined from patient samples - 4000 plasma, 900 urine, and 500 skeletal muscle samples. Conclusions: A rigorously quantitative, accurate, and precise method for acylcarnitine analysis in plasma, urine, and tissue samples is presented. Chromatographic separation of isomeric acylcarnitines allows for detailed analysis of patient samples not possible by TMS/NBS.

Charles Hoppel completed his M.D. at St. Louis University School of Medicine and did his residency in Internal Medicine at the University of Kansas in Kansas City, Kansas. He then did postdoctoral studies at Western Reserve University School of Medicine. He is a Professor of Pharmacology and Medicine, and director of the Center for Mitochondrial Diseases at Case Western Reserve University School of Medicine He has published more than 250 papers in reputed journals.